Thursday, February 10, 2022 9:45:15 AM
I think the decision you made with respect to PSTI is valid, given YOUR analysis of the company's chances, and taking into account a whole range of personal factors, including financial goals, personal status, and a whole range of other factors.
As for me, even-though I'm disappointed with the pace of progress (on the PPS side, not the science and technology), I'm still a believer in the technology and the ability of Pluristem to find the right niche (or niches) to bring the accumulated knowledge to fruition in the market place.
Stem cell technology is moving forward, and it's important to be aware that no company has had a huge marked breakout as yet. But I do believe it's coming, and also that Pluristem has a good chance of participating. If they do, it will be big! This is MY analysis, and it's as good or bad as yours.
In any case, I regret that you are leaving, we need as many civilized, reasonable commentators on this board as we can get.
Best of Luck in your future endeavors!
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM